'Game changer' experimental drug doubles survival time for pancreatic cancer, trial shows
|
A Phase 3, 500-person trial pitted the once-a-day pill
against standard chemotherapy in patients who had already gone through one
unsuccessful round of traditional cancer treatment. The research found the
pill, ... |